Skip to main content
. Author manuscript; available in PMC: 2017 Jun 12.
Published in final edited form as: Reg Anesth Pain Med. 2016 Jan-Feb;41(1):28–36. doi: 10.1097/AAP.0000000000000332

TABLE 4.

Summary of the Secondary Outcomes

Character/Incidence Lidocaine Group Epidural Group P
Hypotension*
POD 1     4 (107), 3.7%   28 (107), 26.1% <0.0001
POD 2     2 (99), 2%   13 (104), 12.5% 0.013
POD 3     0 (60), 0%     7 (93), 7.5% 0.045
POD 4     0 (35), 0%     1 (71), 1.4% 1
Postoperative nausea and vomiting (PONV)*
  POD 1   14 (107), 13%   27 (107), 25.2% 0.090
  POD 2   12 (99), 12.1%   28 (103), 27.1% 0.042
  POD 3     8 (60), 13.3%   19 (91), 20.8% 0.435
  POD 4     4 (35), 11.4%   20 (70), 28.5% 0.141
Pruritus*
  POD 1     3 (106), 2.8%   38 (103), 27.1% <0.0001
  POD 2     1 (99), 1%   40 (103), 38.8% <0.0001
  POD 3     1 (61), 1.6%   32 (92), 34.7% <0.0001
  POD 4     2 (35), 5.7%   26 (70), 37.1% 0.004
Urine retention*
  POD 1     3 (107), 2.8%     7 (54), 12.9% 0.035
  POD 2     3 (99), 3%     9 (64), 14% 0.029
  POD 3     3 (61), 4.9%     5 (68), 7.3% 0.723
  POD 4     1 (36), 2.7%     2 (55), 3.6% 1
Patient pain management satisfaction (yes)*
  POD 1   79 (107), 73.8%   77 (102), 75.4% 1
  POD 2   72 (99), 72.7%   82 (102), 80.3% 0.718
  POD 3   40 (58), 68.9%   84 (91), 92.3% 0.309
  POD 4   25 (34), 73.5%   67 (70), 95.7% 0.493
Time for first ambulation,h   40 (22, 55)   44 (26, 70) 0.252
Time for urinary catheter removal,h   26 (20, 58)   50 (37, 96) <0.0001
Time for first return of bowel function,h   61 (41,85)   84 (53, 107) 0.019
Duration of hospital stay,h 120 (75, 168) 144 (102, 193) 0.081
*

Presented as frequency, P value from χ2 or Fisher exact tests.

Presented as median and (IQR), P value from Mann-Whitney U test.

All these measurements calculated from the time the patient left the theater.